| 周玲,吴娟娟,葛婷婷,梁惠,王秀梅.肺癌患者复发恐惧与疾病感知和心理灵活性的关系[J].四川精神卫生杂志,2024,37(3):262-266.Zhou Ling,Wu Juanjuan,Ge Tingting,Liang Hui,Wang Xiumei,Relationship between fear of relapse and illness perception and psychological flexibility in patients with lung cancer[J].SICHUAN MENTAL HEALTH,2024,37(3):262-266 |
| 肺癌患者复发恐惧与疾病感知和心理灵活性的关系 |
| Relationship between fear of relapse and illness perception and psychological flexibility in patients with lung cancer |
| 投稿时间：2023-03-28 |
| DOI：10.11886/scjsws20230328001 |
| 中文关键词: 肺癌 复发恐惧 疾病感知 心理灵活性 |
| 英文关键词:Lung cancer Fear of relapse Illness perception Psychological flexibility |
| 基金项目:国家中医药管理局国家中医临床研究基地业务建设科研专项课题（项目名称：益气养阴汤联合厄洛替尼治疗中晚期肺腺癌的疗效观察，项目编号：JDZX2015074） |
|
| 摘要点击次数: |
| 全文下载次数: |
| 中文摘要: |
| 背景 肺癌是发病率、死亡率均较高的恶性肿瘤。疾病复发恐惧会影响患者的治疗依从性，降低生活质量。既往已有关于肺癌复发恐惧与疾病感知、疾病感知与心理灵活性二者之间的关系，但关于肺癌患者复发恐惧现状及其与疾病感知、心理灵活性三者相关性的研究较少。目的 探讨肺癌患者复发恐惧及其与疾病感知、心理灵活性的关系，为后续开展相关临床干预提供参考。方法 选取2021年1月—2022年7月阜阳市人民医院收治的96例经病理检查确诊为肺癌的患者作为研究对象。采用恐惧疾病进展简化量表（FoP-Q-SF）、简易疾病感知问卷（BIPQ）、接纳与行动问卷（AAQ-Ⅱ）进行评定。采用Pearson相关分析考查各量表评分的相关性，采用多元线性回归分析探讨肺癌患者复发恐惧的影响因素。结果 肺癌患者FoP-Q-SF总评分为（35.35±7.66）分，且FoP-Q-SF评分≥34分者共65例（67.71%）。相关分析显示，肺癌患者BIPQ总评分与Fop-Q-SF总评分、社会家庭维度评分和生理健康维度评分均呈正相关（r=0.586、0.445、0.475，P均<0.05），AAQ-Ⅱ评分与FoP-Q-SF总评分、社会家庭维度评分、生理健康维度评分呈正相关（r=0.485、0.652、0.513，P均<0.05）。多元线性回归分析显示，年龄（β=-0.142，P<0.01）、受教育程度（β=-0.254，P<0.01）、家庭月收入（β=-0.527，P<0.01）、疾病感知（β=0.847，P<0.01）、心理灵活性（β=0.781，P<0.01）均是肺癌患者复发恐惧的影响因素。结论 大部分肺癌患者存在复发恐惧，不仅与疾病感知和心理灵活性有关，还受年龄、受教育程度和家庭月收入等因素的影响。 |
| 英文摘要: |
| Background Lung cancer is a malignancy of high incidence rate and mortality in China. The fear of relapse can affect the patient's treatment compliance and reduce their quality of life. There have been previous studies on the relationship between fear of lung cancer relapse and disease perception， as well as disease perception and psychological flexibility. However， current research on the status quo of fear of lung cancer relapse and its correlation with illness perception and psychological flexibility is limited.Objective To explore the fear of cancer relapse and its relations with illness perception and psychological flexibility in patients with lung cancer， and to provide references for subsequent related clinical interventions.Methods A total of 96 patients were selected as the research subjects， who were pathologically diagnosed with lung cancer and admitted to Fuyang People's Hospital from January 2021 to July 2022. Fear of Progression Questionnaire-Short Form （FoP-Q-SF）， Brief Illness Perception Questionnaire （BIPQ） and Acceptance and Action Questionnaire-Ⅱ （AAQ-Ⅱ） were used for evaluation. Pearson correlation analysis was used to examine the correlation between scores of various scales， and multiple linear regression analysis was used to explore the influencing factors of relapse fear in lung cancer patients.Results The total FoP-Q-SF score of lung cancer patients was （35.35±7.66） and a total of 65 cases （67.71%） had a FoP-Q-SF score≥34. As relevant analyses showed， the BIPQ total score of lung cancer patients was positively correlated with the total score， social family dimension score and physiological health dimension score of Fop-Q-SF （r=0.586， 0.445， 0.475， P<0.05）， the AAQ-Ⅱ score was positively correlated with the total score， social family dimension score and physiological health dimension score of FoP-Q-SF （r=0.485， 0.652， 0.513， P<0.05）. According to the results of single factor analysis and multiple linear regression analysis， age （β=-0.142， P<0.01）， education level （β=-0.254， P<0.01）， monthly household income （β=-0.527， P<0.01）， illness perception （β=0.847， P<0.01） and psychological flexibility （β=0.781， P<0.01） are all factors influencing the fear of relapse in lung cancer patients.Conclusion Most lung cancer patients have a fear of recurrence. It is not only related to illness perception and psychological flexibility， but also influenced by factors including age， education level and monthly family income.［Funded by Special Research Project on Business Construction of National Clinical Research Base of Traditional Chinese Medicine under the State Administration of Traditional Chinese Medicine （number， JDZX2015074）］ |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |